首页> 外文期刊>BJU international >The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma.
【24h】

The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma.

机译:透明细胞肾细胞癌中肿瘤周围调节性T细胞的预后价值及其与肿瘤内环氧合酶-2表达的相关性。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To investigate the prognostic value of regulatory T cells (Tregs) and its correlation with cyclooxygenase-2 (COX-2) expression in clear cell renal cell carcinoma (RCC). PATIENTS AND METHODS: CD4+, Foxp3+ tumour-infiltrating lymphocytes and tumour COX-2 expression were assessed by immunohistochemistry in tissue microarrays containing RCC from 125 patients. Prognostic effects of low and high expression were evaluated by Cox regression and Kaplan-Meier analysis using the median values as thresholds. The expression of Tregs and COX-2 were compared with the clinicopathological variables. In addition, Tregs and its correlation with COX-2 expression was also analysed. RESULTS: Peritumoral Tregs were positively correlated with intratumoral COX-2 expression (Spearman rank correlation 0.336, P < 0.001). Peritumoral Tregs were associated with TNM stage (P = 0.001) and tumour size (P = 0.002), while intratumoral COX-2 expression was associated with TNM stage (P = 0.018) and grade (P = 0.013). Using multivariate analysis, increased peritumoral Tregs, higher TNM stage (III + IV), larger tumour size (> or =7 cm) and higher nuclear grade (III + IV) were independent predictors for significantly shorter overall survival and disease-free survival. CONCLUSIONS: Increased peritumoral Tregs are associated with worse prognosis in clear cell RCC. The high intratumoral COX-2 expression may be the underlying reason for the aberrant gathering of Tregs. These results suggest that clinical application of COX-2 inhibitors may benefit those patients with higher intratumoral COX-2 immunostaining by reducing the transformation of Tregs in RCC.
机译:目的:探讨在透明细胞肾细胞癌(RCC)中调节性T细胞(Tregs)的预后价值及其与环氧合酶-2(COX-2)表达的相关性。患者和方法:采用免疫组织化学方法对125例患者的RCC组织芯片进行CD4 +,Foxp3 +肿瘤浸润淋巴细胞和肿瘤COX-2表达的评估。通过中位数作为阈值,通过Cox回归和Kaplan-Meier分析评估低表达和高表达的预后效果。将Tregs和COX-2的表达与临床病理变量进行比较。另外,还分析了Treg及其与COX-2表达的相关性。结果:周周Tregs与肿瘤内COX-2表达呈正相关(Spearman等级相关为0.336,P <0.001)。瘤周Tregs与TNM分期(P = 0.001)和肿瘤大小(P = 0.002)相关,而瘤内COX-2表达与TNM分期(P = 0.018)和分级相关(P = 0.013)。使用多变量分析,肿瘤周Treg升高,TNM分期更高(III + IV),肿瘤大小更大(>或= 7 cm)和更高的核分级(III + IV)是独立预测因素,可显着缩短总体生存期和无病生存期。结论:肿瘤周围Tregs升高与透明细胞RCC预后较差有关。肿瘤内高的COX-2表达可能是Tregs异常聚集的根本原因。这些结果表明,COX-2抑制剂的临床应用可通过减少RCC中Tregs的转化使那些肿瘤内COX-2免疫染色更高的患者受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号